Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
06/2003
06/11/2003EP1318160A1 Catalysts and process for the preparation of isocyanurate group containing polyisocyanates and their use
06/11/2003EP1318156A1 Novel asymmetric phosphine ligand
06/11/2003EP1318155A1 Novel asymmetric phosphine ligand
06/11/2003EP1318154A1 Compounds for determination of the activity of phospholipase A2
06/11/2003EP1318143A1 Rare-earth ternary complex
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317253A2 Biological component comprising artificial membrane
06/11/2003EP1216253B1 Process for preparing methylene bisphosphonic acids and salts thereof
06/11/2003EP1105372B1 Methoximinophenylacetic acid amides
06/11/2003EP1023300B1 Carbon dioxide assisted hydrolysis of aminophosphonates
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0944638B1 Cis-bridged metal complexes
06/11/2003CN1423653A Mixed metal alkoxide complexes and polymerization catalysts made therefrom
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/11/2003CN1423629A Metathesis synthesis of pheromones or their components
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1111165C Aldehyde acetal modified quaternary phosphate and its preparing method and use
06/11/2003CN1111164C Process for preparing 1-hydroxyl-1-carboxylfatty phosphonic acid
06/10/2003US6576783 Oligonucleotide protecting groups
06/10/2003US6576782 Halogenation of protected phenols in meta position
06/10/2003US6576779 Catalyst compositions and processes for olefin polymers and copolymers
06/10/2003US6576778 Methods for preparing ruthenium and osmium compounds
06/10/2003US6576772 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
06/10/2003US6576766 Signal transduction inhibitors, compositions containing them
06/10/2003US6576760 Cyclization of a substituted polyamine having secondary amino groups by reaction with a bridging agent having two reactive groups each capable of nucleophilic attack by one of the secondary amine groups of the polyamine; chelate compound
06/10/2003US6576684 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives
06/10/2003US6576672 Parkingson's Disease and dementias characterized by mito-chondrial damage; such as 3,7-diazanonane-1,9-diamine; neutralizing dopamine depriving effect
06/10/2003US6576655 To produce polymers; cancer therapy
06/10/2003US6576627 Phosphonic acid derivatives having carboxypeptidase b inhibitory activity
06/10/2003US6576626 Treating gastro-oesophageal reflux disease
06/10/2003US6576161 Halogen-free, oligomeric, phosphate based, non-migrating flame retardant
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2232775C Acyl compounds
06/10/2003CA2130675C Synthesis of stable, water-soluble chemiluminescent 1,2-dioxetanes and intermediates therefor
06/05/2003WO2003046049A1 Polymeric, phosphorous-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
06/05/2003WO2003046019A1 Supported bis(phosphorus)ligands and their use in the catalysis
06/05/2003WO2003045961A1 Preparation of crystalline polymorphs of fosinopril sodium
06/05/2003WO2003045960A1 Phosphorus-borates with low melting points
06/05/2003WO2003045897A1 Neorologically-active compounds
06/05/2003WO2003045555A2 Process for the preparation of a nickel/phosphorus ligand catalyst for olefin hydrocyanation
06/05/2003WO2003045552A2 Polymeric phosphorus-containing compositions and their use in hydrocyanation, unsaturated nitrile isomerization and hydroformylation reactions
06/05/2003WO2002088149A3 A process for manufacture of fosinopril sodium
06/05/2003US20030105361 Polymerization catalyst
06/05/2003US20030105345 Processes for the preparation of phosphonic esters
06/05/2003US20030105279 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/05/2003US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity
06/05/2003US20030105065 Novel quinolines and uses thereof
06/05/2003US20030105056 Used to produce amino- modified linkers that space an oligonucleotide from a solid support
06/05/2003US20030104476 Made by reacting a halophosphine compound with said polymer; use making metal-complexed catalysts; coumarin by catalyzed reaction of salicylaldehyde and an alkyl acrylate
06/05/2003CA2468416A1 Phosphorus-borates with low melting points
06/05/2003CA2468293A1 Process for the preparation of a nickel/phosphorus ligand catalyst for olefin hydrocyanation
06/05/2003CA2468195A1 Polymeric phosphorus-containing compositions and their use in hydrocyanation, unsaturated nitrile isomerization and hydroformylation reactions
06/05/2003CA2468129A1 Polymeric, phosphorous-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
06/05/2003CA2468127A1 Supported bis(phosphorus)ligands and their use in the catalysis
06/05/2003CA2467884A1 Preparation of crystalline polymorphs of fosinopril sodium
06/05/2003CA2413399A1 Catalysts for preparing polyisocyanates containing isocyanurate groups, and their use
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315698A1 Pyrrolidines as inhibitors of neuraminidases
06/04/2003EP1315506A2 Phospholipid derivatives of valproic acid and mixtures thereof
06/04/2003EP1064093B1 Catalyst comprising a rhodium complex based on a a phosphonite ligand and method for hydroformylation
06/04/2003EP1062358B1 Novel method for preparing fexofenadine
06/04/2003EP1028721B1 N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
06/04/2003CN1422275A Removal of chloride from phosphonomethyliminodiacetic acid process
06/04/2003CN1421451A 9-[2-[[[di (trimethylacetoxyl) methyl phosphoroso] methoxy]-ethyl] adenine crystal and its prepn and crystal application
06/04/2003CN1421450A Prepn of 9 [2-[[[di (trimethylacetoxyl) methyl] phosphoros]-methoxy-ethyl] adenine
06/04/2003CN1421449A 9-[2-[[[di (trimethylacetoxyl) methyl] phosphoroso] methoxy]-ethyl] adenine crystal and its prepn and crystal application
06/04/2003CN1421448A Preparation of diethyl phosphoric acid
06/04/2003CN1110492C Prodrugs of aspartyl protease inhibitors
06/03/2003USRE38132 Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
06/03/2003US6573407 R1 to R4 represent hydrogen atom or a group that can be a substituent on a benzene represents hydrogen atom or an alkyl group; and R6 to R8 represent an alkyl group, an aryl group, a heterocyclic group etc.). Reducig agent and images with
06/03/2003US6573401 Reacting 4-aminobutyric acid with a phosphonation mixture of phosphorous acid and methanesulfonic anhydride, hydrolyzing the resulting reaction product, isolation by an appropriate pH adjustment, free acid or monosodium salt
06/03/2003US6573389 Bidentate organophosphorous ligands and their use
06/03/2003US6573378 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine having a purity of greater than 95% by weight or it's sodium salt
06/03/2003US6573374 Using carbocyanine group attached to base portion; less background interference
06/03/2003US6573295 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
06/03/2003US6572789 Phosphinosuccinic acids and oligomers
05/2003
05/30/2003WO2003044030A1 Multimer forms of acylphosphines and their derivatives
05/30/2003WO2003044029A1 Method for the production of organodiphosphonites
05/30/2003WO2003044011A1 Pyrrole synthesis
05/30/2003WO2003043735A2 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions
05/30/2003WO2003018552A3 Aromatic and heteroaromatic acid halides for synthesizing polyamides
05/30/2003WO2002085848A8 Synthesis of pancratistatin prodrugs
05/30/2003WO2002041827A9 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
05/30/2003CA2467576A1 Multimer forms of acylphosphines and their derivatives
05/30/2003CA2464314A1 Pyrrole synthesis
05/29/2003US20030100788 Continuously reacting phosphorus oxychloride with ethanol under reduced pressure, scrubbing, then distilling to obtain water and ethanol for recirculation
05/29/2003US20030100787 One pot process of reacting 2,4-dialkyl phenol with phosphorous trihalide in methylene chloride with pyridine
05/29/2003US20030100776 Allows for substitution of functional groups within the olefin without comprising efficiency of metathesis
05/29/2003US20030100761 Process for synthesizing ionic metal complex
05/29/2003US20030100689 Polymerisation catalyst
05/29/2003US20030100573 For treatment of debilitating bone disorders; anticancer agents
05/29/2003US20030100572 Such as (4-(6-(2,6-dichlorophenyl)-8-methyl-7-oxo-4a,7,8,8a -tetrahydropyrido(2,3)pyrimidin-2-ylamino)-phenyl)-phosphono -methyl)phosphonic acid for treatment of bone disorders and cancer
05/29/2003US20030100555 Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
05/29/2003US20030100538 Substituted chalcones as therapeutic compounds
05/29/2003US20030100537 Calcium (3S) tetrahydro-3-furanyl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phos-phonooxy)propylcarbamate
05/29/2003US20030100442 Process for the preparation of a nickel/phosphorous ligand catalyst for olefin hydrocyanation
05/29/2003US20030100441 Polymerization of olefin
05/29/2003US20030099981 Process for the preparation of phosphorothioate triesters
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 554